- Advanced Diagnostics & Radiotherapy: State-of-the-art imaging and precise radiation therapies.
- Nuclear Medicine: Specialized systemic radionuclide therapy.
- Personalized Therapy: Molecular-targeted oncology treatments tailored to individual tumor genetics.
- Rehabilitation: Dedicated post-treatment care and recovery services for cancer patients.
- Scientific Leadership: The Institute chairs the Problem Commission on Oncology for Siberia and the Far East, providing clinical and methodological guidance to regional cancer centers
Its core areas of clinical and research focus includes
The institute focuses on the following primary areas
Molecular Pathogenesis: Translating basic science into clinical practice by studying the molecular and genetic mechanisms of tumor development.
Personalized & Ethnic Care: Optimizing cancer services by accounting for the unique ethno-population characteristics and genetic profiles of the region's diverse inhabitants
Prognostic Markers: Studies the body's life support systems and molecular features of tumors to develop criteria for cancer prognosis. This forms the foundation for targeted therapy, immunotherapy, and ethno-oriented treatments.
Combination Therapies: Develops innovative drug regimens and efficacy modifiers.
Advanced Interventions: Improves organ-preserving surgical reconstructions, interdisciplinary rehabilitation measures, and introduces innovative radiopharmaceuticals for clinical diagnosis and treatment
1
/
5